Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis.
Ann Allergy Asthma Immunol
; 126(6): 696-701.e1, 2021 06.
Article
in En
| MEDLINE
| ID: mdl-33548468
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-5
/
Anti-Asthmatic Agents
/
Eosinophilia
/
Antibodies, Monoclonal, Humanized
Type of study:
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Allergy Asthma Immunol
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2021
Document type:
Article
Country of publication:
United States